Seres Therapeutics to Present at the Oppenheimer 32nd Annual Healthcare ConferenceBusiness Wire • 03/10/22
Seres Therapeutics to Participate in Cowen 42nd Annual Health Care ConferenceBusiness Wire • 03/03/22
Seres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/01/22
Seres Therapeutics (MCRB) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 03/01/22
Seres Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdatesBusiness Wire • 03/01/22
Seres Therapeutics to Present at Chardan Metagenomics and Microbiome Medicines SummitBusiness Wire • 02/22/22
Seres Therapeutics to Host Fourth Quarter 2021 Financial Results and Operational Progress Conference Call and Webcast on March 1, 2022Business Wire • 02/22/22
Seres Therapeutics Appoints Paula Cloghessy as Executive Vice President, Chief People OfficerBusiness Wire • 02/08/22
Seres Therapeutics to Host Virtual Investor Event Highlighting Opportunities for Microbiome Therapeutics in Infection Protection on January 31, 2022Business Wire • 01/24/22
Seres Therapeutics' Oral Microbiome Candidate Shows Meaningful Improvements In Difficile InfectionBenzinga • 01/20/22
New England Journal of Medicine Publishes Data from ECOSPOR lll Phase 3 Study Evaluating Investigational Microbiome Therapeutic SER-109 in Recurrent C. Difficile InfectionBusiness Wire • 01/19/22
Seres Therapeutics to Present at 40th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/04/22
Seres Announces Preliminary SER-287 Phase 2b ECO-RESET Study Microbiome Data AnalysisBusiness Wire • 12/16/21
Will The Rally Continue In Seres Therapeutics (MCRB) Stock After A Stellar 77% Surge In A Month?Forbes • 12/02/21
Seres Therapeutics Announces First Patient Enrolled in Phase 1b Study of SER-155, an Investigational Microbiome Therapeutic to Reduce the Risk of Antibiotic-Resistant Bacterial Infections and Graft-Versus-Host Disease (GvHD)Business Wire • 11/30/21
Seres Therapeutics to Present at Piper Sandler 33rd Annual Virtual Healthcare ConferenceBusiness Wire • 11/24/21
Seres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/21
Seres Therapeutics (MCRB) Q3 Earnings and Revenues Beat EstimatesZacks Investment Research • 11/10/21
Seres Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business UpdatesBusiness Wire • 11/10/21